Ayala-Grosso C, Tam J, Xanthoudakis S, Bureau Y, Roy S, Nicholson D W, Robertson G S
Department of Pharmacology and Therapeutics, McGill University, McIntyre Medical Sciences Building, 3655 Promenade Sir-William-Osler, Montreal, Canada H3G 1Y6.
Neuroscience. 2004;126(4):927-40. doi: 10.1016/j.neuroscience.2004.04.048.
The ability of fimbria-fornix bilateral axotomy to elicit calpain and caspase-3 activation in the rat septohippocampal pathway was determined using antibodies that selectively recognize either calpain- or caspase-cleaved products of the cytoskeletal protein alphaII-spectrin. Radioenzymatically determined choline acetyl transferase (ChAT) activity was elevated in the septum at day 5, but reduced in the dorsal hippocampus at days 3, 5 and 7, after axotomy. Prominent accumulation of calpain-, but not caspase-3-, cleaved spectrin proteolytic fragments was observed in both the septum and dorsal hippocampus 1-7 days after axotomy. ChAT-positive neuronal cell bodies in the septum also displayed calpain-cleaved spectrin indicating that calpain activation occurred in cholinergic septal neurons as a consequence of transection of the septohippocampal pathway. Calpain-cleaved alphaII-spectrin immunoreactivity was observed in cholinergic fibers coursing through the fimbria-fornix, but not in pyramidal neurons of the dorsal hippocampus, suggesting that degenerating cholinergic nerve terminals were the source of calpain activity in the dorsal hippocampus following axotomy. Accumulation of calpain-cleaved spectrin proteolytic fragments in the dorsal hippocampus and septum at day 5 after axotomy was reduced by i.c.v. administration of two calpain inhibitors. Calpain inhibition partially reduced the elevation of ChAT activity in the septum produced by transection but failed to decrease the loss of ChAT activity in the dorsal hippocampus following axotomy. These findings suggest that calpain activation contributes to the cholinergic cell body response and hippocampal axonal cytoskeletal degradation produced by transection of the septohippocampal pathway.
利用能选择性识别细胞骨架蛋白αII-血影蛋白的钙蛋白酶或半胱天冬酶裂解产物的抗体,确定了穹窿-海马伞双侧轴突切断术引发大鼠隔海马通路中钙蛋白酶和半胱天冬酶-3激活的能力。轴突切断术后第5天,隔区经放射酶法测定的胆碱乙酰转移酶(ChAT)活性升高,但在第3、5和7天,背侧海马中的ChAT活性降低。轴突切断术后1-7天,在隔区和背侧海马中均观察到钙蛋白酶裂解的血影蛋白蛋白水解片段显著积累,但未观察到半胱天冬酶-3裂解的片段积累。隔区中ChAT阳性神经元细胞体也显示出钙蛋白酶裂解的血影蛋白,表明由于隔海马通路横断,胆碱能隔区神经元中发生了钙蛋白酶激活。在穿过穹窿-海马伞的胆碱能纤维中观察到钙蛋白酶裂解的αII-血影蛋白免疫反应性,但在背侧海马的锥体神经元中未观察到,这表明轴突切断术后,退化的胆碱能神经末梢是背侧海马中钙蛋白酶活性的来源。轴突切断术后第5天,通过脑室内注射两种钙蛋白酶抑制剂,可减少背侧海马和隔区中钙蛋白酶裂解的血影蛋白蛋白水解片段的积累。钙蛋白酶抑制部分降低了横断引起的隔区ChAT活性升高,但未能减少轴突切断术后背侧海马中ChAT活性的丧失。这些发现表明,钙蛋白酶激活有助于隔海马通路横断所产生的胆碱能细胞体反应和海马轴突细胞骨架降解。